2016. Targeted-delivery of chemotherapy (NANOLEUK) vs standard chemotherapy in acute myeloid leukemia: a proposed randomized, double-blinded, multicenter efficacy trial. Principles and Practice of Clinical Research. 2, 2 (Nov. 2016).